1. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New Engl J Med. 2010;363(27):2587–99. https://doi.org/10.1056/NEJMoa1011205.
2. Centers for Disease Control and Prevention. Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 update: a clinical practice guideline. Atlanta: US Public Health Service, CDC; 2018.
3. Smith DK, Thigpen MC, Nesheim SR, Lampe MA, Paxton LA, Samandari T, et al. Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults. MMWR Morb Mortal Wkly Rep. 2012;61(31):586–9.
4. U.S. Food and Drug Administration. FDA approves first injectable treatment for HIV pre-exposure prevention. 2021. Available: https://www.fda.gov/news-events/press-announcements/fda-approves-first-injectable-treatment-hiv-pre-exposure-prevention. Accessed 15 Sept 2023.
5. Centers for Disease Control and Prevention (CDC). Pre-Exposure Prophylaxis (PrEP). 2022. Available: https://www.cdc.gov/hiv/risk/prep/index.html. Accessed15 Sept 2023.